PARIS, Sept. 18, 2026 /PRNewswire/ --  
Virbac Headquarters, Carros, France ・H1 2026 delivered a robust revenue growth of +7.4% and an adjusted EBIT margin of 18.8% at CERS: ○  Revenue growth is coming from both segments : companion animal +10.0% and farm animal +6.7% with a strong contribution from our Supercharge platforms (excl. Thyronorm) which increased by around +12% at CERS
○  Solid volume/mix effect of ~+5.4%, completed by price increase of ~+2%
○  Operating margin increased by 0.5ppt compared to H1 2025 driven by a favorable mix effect on the gross margin partially off…READ FULL ARTICLE